Cardinal HealthRegister for a premium account to gain access to Sterling AI.
Get StartedThings you can ask Sterling:
Cardinal HealthThird of the big three US drug distributors, also a medical products manufacturer. GLP-1 sales rose significantly across fiscal 2024 and 2025 and lifted reported revenue, but the company disclosed that they did not meaningfully contribute to segment profit.
2021-Q2-2026-Q1
2021-Q2-2026-Q1
1994-2025
$CAH
Third of the big three US distributors. GLP-1 sales rose significantly across fiscal 2024 and 2025 and lifted reported revenue, but Cardinal disclosed that they did not meaningfully contribute to segment profit, the clearest statement of the distribution margin problem.